To investigate whether elevated FGF23-FGFR4 signaling might directly contribute to the cardiac metabolic remodeling observed in CKD, we studied cardio-bundles, 3-dimensional multicellular cylindrical tissues bio-engineered from neonatal rat ventricular myocytes (NRVM) and fibroblasts. This evidence concerns the gene FGFR4 and chronic kidney disease.